HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
MARCKS
myristoylated alanine rich protein kinase C substrate
Chromosome 6 · 6q21
NCBI Gene: 4082Ensembl: ENSG00000277443.4HGNC: HGNC:6759UniProt: P29966
208PubMed Papers
20Diseases
1Drugs
1Pathogenic Variants
RESEARCH IMPACT
Trending
CLINICAL
Clinical Trials
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
extracellular exosomeplasma membranefocal adhesioncentral nervous system developmentneurodegenerative diseasetype 2 diabetes mellituspreeclampsiadiabetes mellitus
✦AI Summary

MARCKS (myristoylated alanine rich protein kinase C substrate) is a membrane-associated protein that plays crucial roles in cytoskeletal organization and cellular signaling. The protein regulates actin filament organization and serves as a bridge between calcium/calmodulin and protein kinase C signaling pathways 1. MARCKS sequesters phosphatidylinositol 4,5-bisphosphate (PIP2) at plasma membrane lipid rafts in quiescent cells, which is reversed by protein kinase C activation 1. Mechanistically, MARCKS functions through calmodulin-dependent translocation that can activate the PI3K/AKT/mTOR pathway 2. The protein requires proper N-myristoylation for its cellular function, as demonstrated by altered MARCKS myristoylation in ACBD6-deficient models 3. MARCKS has significant disease relevance, being implicated in cancer progression and metastasis, particularly in gastric cancer peritoneal metastasis where it marks high-plasticity cancer clusters with poor prognosis 4. In prostate cancer, MARCKS serves as part of a prognostic signature for biochemical recurrence 5. The protein also contributes to hypertension regulation, as human alpha-1 antitrypsin treatment reduces MARCKS expression alongside blood pressure reduction in diabetic mice 6. Additionally, MARCKS is co-regulated with APOE in brain cells and linked to Alzheimer's disease pathogenesis 7.

Sources cited
1
MARCKS binds actin filaments, bridges Ca2+/calmodulin and PKC signaling, and sequesters PIP2 in plasma membrane
PMID: 30339463
2
MARCKS undergoes calmodulin-dependent translocation that activates PI3K/AKT/mTOR pathway
PMID: 38755678
3
MARCKS requires proper N-myristoylation for function, altered in ACBD6 deficiency
PMID: 37951597
4
MARCKS marks high-plasticity gastric cancer clusters with poor prognosis
PMID: 36788228
5
MARCKS is part of prognostic signature for prostate cancer biochemical recurrence
PMID: 38221616
6
MARCKS expression is reduced by alpha-1 antitrypsin treatment alongside blood pressure reduction
PMID: 36671451
7
MARCKS is co-regulated with APOE in brain cells and linked to Alzheimer's disease
PMID: 38699303
Disease Associationsⓘ20
neurodegenerative diseaseOpen Targets
0.47Moderate
type 2 diabetes mellitusOpen Targets
0.33Weak
preeclampsiaOpen Targets
0.31Weak
diabetes mellitusOpen Targets
0.29Weak
salivary gland diseaseOpen Targets
0.27Weak
smoking initiationOpen Targets
0.26Weak
Alzheimer diseaseOpen Targets
0.20Weak
urinary system diseaseOpen Targets
0.19Weak
celiac diseaseOpen Targets
0.19Weak
oral mucosa leukoplakiaOpen Targets
0.18Weak
cervical carcinomaOpen Targets
0.17Weak
connective tissue diseaseOpen Targets
0.17Weak
ArthropathyOpen Targets
0.15Weak
placental retentionOpen Targets
0.15Weak
non-small cell lung carcinomaOpen Targets
0.10Weak
neoplasmOpen Targets
0.10Suggestive
chronic obstructive pulmonary diseaseOpen Targets
0.10Suggestive
melanomaOpen Targets
0.10Suggestive
lung cancerOpen Targets
0.10Suggestive
inflammatory breast carcinomaOpen Targets
0.09Suggestive
Pathogenic Variants1
NM_002356.7(MARCKS):c.616_632del (p.Glu206fs)Likely pathogenic
not specified
★☆☆☆2020→ Residue 206
View on ClinVar ↗
Drug Targets1
BIO-11006Phase II
Myristoylated alanine-rich C-kinase substrate inhibitor
chronic obstructive pulmonary disease
Related Genes
CALM1Protein interaction100%CALM2Protein interaction100%CALM3Protein interaction100%CALML3Protein interaction100%GAP43Protein interaction100%PRKCEProtein interaction92%
Tissue Expression6 tissues
Brain
100%
Bone Marrow
88%
Lung
19%
Ovary
15%
Heart
12%
Liver
7%
Gene Interaction Network
Click a node to explore
MARCKSCALM1CALM2CALM3CALML3GAP43PRKCE
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt P29966
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.86LoF Tolerant
pLIⓘ
0.01Tolerant
Observed/Expected LoF1.11 [0.56–1.86]
RankingsWhere MARCKS stands among ~20K protein-coding genes
  • #2,010of 20,598
    Most Researched208 · top 10%
  • #4,721of 5,498
    Most Pathogenic Variants1
  • #16,923of 17,882
    Most Constrained (LOEUF)1.86
Genes detectedMARCKS
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis.
PMID: 36788228
Nat Commun · 2023
1.00
2
Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
PMID: 38221616
J Transl Med · 2024
0.90
3
Patent landscape highlighting therapeutic implications of peptides targeting myristoylated alanine-rich protein kinase-C substrate (MARCKS).
PMID: 37526024
Expert Opin Ther Pat · 2023
0.84
4
MARCKS and Lung Disease.
PMID: 30339463
Am J Respir Cell Mol Biol · 2019
0.80
5
CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation.
PMID: 38755678
Mol Cancer · 2024
0.70